OPTHEA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.49 AUD | -4.85% |
|
-16.95% | -14.04% |
| 28/05 | Opthea Limited Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD | CI |
| 28/05 | Opthea Completes Enrollments in COAST, ShORe Trials | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 228M | - | |||||
| 56.65B | - | |||||
| 39.44B | ||||||
| 39.03B | ||||||
| 26.75B | ||||||
| 26.86B |
- Stock Market
- Equities
- OPT Stock
- Charts Opthea Limited
- Sector Chart
